Therapy News and Research

RSS

Seizure risk should not influence AVM treatment decisions

Choosing to treat patients with arteriovenous malformations surgically rather than conservatively has no bearing on their risk for seizures, suggest findings from the Scottish Audit of Intracranial Vascular Malformations.

10 Jul 2012

Mechanical treatment shows promise in thalassemia

Vibration therapy may be an effective nonpharmacologic intervention to increase bone mass in patients with thalassemia, US researchers report

10 Jul 2012

Surgery advised in face of uncertain sinus sampling result in Cushing patients

Surgeons should consider transsphenoidal surgery in patients with Cushing disease caused by adrenocorticotropic hormone overproduction, almost irrespective of the results of inferior petrosal sinus sampling, say US researchers.

10 Jul 2012

Two-drug combo increases diabetes patients’ goal achievement

Post-hoc analysis of randomized trial results shows that treating individuals with Type 2 diabetes with a combination of phentermine and topiramate increases their achievement of goals recommended for the management of their condition.

10 Jul 2012

Phase III darexaban results revealed

The direct oral factor Xa inhibitor darexaban is effective for the prevention of venous thromboembolism in Japanese patients undergoing major abdominal surgery, researchers find.

10 Jul 2012

Osteopathic technique effective for people with work-related dysphonia

Vocal tract function can be substantially improved by the use of osteopathic myofascial techniques in people with work-related voice disorders, suggest study results.

10 Jul 2012

Photodynamic therapy promising after failed chemo for ESCC

Photodynamic therapy is a potentially curative and tolerable salvage treatment option for patients with esophageal squamous cell carcinoma when chemoradiotherapy has failed, report researchers.

10 Jul 2012

Lesogaberan development halts following disappointing results

Lesogaberan is only marginally superior to placebo in gastroesophageal reflux disease patients who are partially responsive to proton pump inhibitor therapy, results show.

10 Jul 2012

Neuroprotective effects underpin fingolimod benefits in MS

Fingolimod therapy reduces inflammatory activity and tissue loss in the brains of patients with multiple sclerosis, shows further analysis of the FREEDOMS trial.

10 Jul 2012

Radiotherapy redundant in low-risk Hodgkin lymphoma treatment

Children with low-risk Hodgkin lymphoma who respond well to chemotherapy may not require additional radiotherapy, suggest study results.

10 Jul 2012

Diaphragm muscles show osteopathic training potential

Osteopathic manipulative intervention to obtain functional equilibrium of the diaphragm increases lower esophageal sphincter pressure in patients with gastroesophageal reflux disease, researchers have found.

10 Jul 2012

Relaxin key to improved stroke rehabilitation outcomes

Treatment with the reproductive hormone relaxin during physical rehabilitative therapy appears to improve long-term outcomes in stroke patients over rehabilitative therapy alone, say researchers.

10 Jul 2012

Book outlines importance of Alzheimer's diagnosis and therapeutic interventions

Karger Medical Publishers Book On Cutting-Edge Alzheimer's Diagnosis and Therapy, with guidance from the Alzheimer's Association. This volume advances emerging concepts for therapeutic interventions and earlier detection and diagnosis of the global epidemic and features internationally leading experts' findings on biomarkers

10 Jul 2012

New devices effectively monitor and control blood sugar levels in people with diabetes

Newer technologies designed to help people with type 1 diabetes monitor their blood sugar levels daily work better than traditional methods and require fewer painful needle sticks, new Johns Hopkins research suggests.

10 Jul 2012

ACADI’s pimavanserin may have therapeutic benefits in treatment of ADP

ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced results of preclinical studies, which suggest that pimavanserin, ACADIA's proprietary product candidate currently in Phase III development for Parkinson's disease psychosis, also may have therapeutic benefits in the treatment of Alzheimer's disease psychosis (ADP).

10 Jul 2012

New blood sugar monitor works better than conventional methods

10 Jul 2012

$Vertebroplasty can benefit patients with osteoporotic vertebral compression fractures$

Vertebroplasty can benefit patients with osteoporotic vertebral compression fractures

An analysis of published data in the medical literature has found that vertebroplasty can provide more pain relief and better function for patients with osteoporotic vertebral compression fractures than nonoperative treatments.

10 Jul 2012

Disabling Nf1 gene makes stem cells from the third ventricle proliferate rapidly

Scientists showed in mice that disabling a gene linked to a common pediatric tumor disorder, neurofibromatosis type 1 (NF1), made stem cells from one part of the brain proliferate rapidly. But the same genetic deficit had no effect on stem cells from another brain region.

10 Jul 2012

FDA approves risk evaluation and mitigation strategy for ER and LA opioids

The U.S. Food and Drug Administration today approved a risk evaluation and mitigation strategy (REMS) for extended-release (ER) and long-acting (LA) opioids, highly potent drugs approved for moderate to severe, persistent pain that requires treatment for an extended period.

10 Jul 2012

Sox10 gene plays a central role in melanoma

Black skin cancer, also known as melanoma, is particularly aggressive and becoming increasingly common in Switzerland. Despite intensive research, however, there is still no treatment. Researchers from the University of Zurich have now discovered a gene that plays a central role in black skin cancer. Suppressing this gene in mice inhibits the development of melanoma and its proliferation - a discovery that could pave the way for new forms of therapy.

10 Jul 2012